Etanercept for Tinnitus
Study Summary
This trial will test whether 2 injections of the drug Etanercept can help treat tinnitus caused by exposure to loud noises.
- Noise-Induced Tinnitus
Eligibility Criteria
Inclusion Criteria
You will be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2015 Phase 4 trial • 491 Patients • NCT01578850Awards & Highlights
Trial Design
Find a site
Who is running the clinical trial?
Media Library
Frequently Asked Questions
How is Etanercept typically employed for medical purposes?
"Etanercept is normally prescribed to alleviate moderate-to-severe symptoms and has been proven useful in treating diseases such as rheumatoid arthritis, ankylosing spondylitis, and others."
Has Etanercept been sanctioned by the United States Food and Drug Administration?
"After assessing the data, our team at Power assigned Etanercept a safety score of 2 due to Phase 2 trial results which confirm its relative security but lack evidence for efficacy."
Could you delineate the myriad of studies conducted utilizing Etanercept?
"Etanercept has been subject to 650 completed studies since its first research at University of Nebraska Medical Center in 2007. Currently, 34 active investigations are being conducted, with multiple sites located in Farmington Hills, Michigan."
Is enrollment for this experiment still available?
"According to the information on clinicaltrials.gov, this medical trial is currently recruiting individuals for participation. The initial posting was made in July 1st 2022 and an edit occurred a few weeks later on July 12th 2022."
What can we anticipate as the outcome from this experiment?
"The purpose of this 36-week trial is to measure the efficacy and safety of Etanercept in reducing tinnitus severity, loudness, and associated anxiety and depression. The primary outcome for tinnitus severity will be assessed using the Tinnitus Functional Index (TFI). As a secondary outcome, subjects must complete a Tinnitus Loudness Matching test while wearing foam earphones in an acoustically treated sound booth. Additionally, patients' self-reported data on their levels of anxiety and depression with Hospital Anxiety & Depression scale (HADS), as well as Visual Numerical Scale (VNS) for self"
How many places are conducting this experiment?
"This research effort is seeking participants from Michigan Ear Institute in Farmington Hills, University of Arizona-AHSC Bldg in Tucson and Wayne State University in Detroit alongside 9 other medical centres."
How many participants are contributing to this research endeavor?
"This trial requires 310 eligible patients to complete it, and they can do this by visiting either Michigan Ear Institute in Farmington Hills or University of Arizona-AHSC Bldg in Tucson."
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Why did patients apply to this trial?
What questions have other patients asked about this trial?
How responsive is this trial?
Typically responds via
Most responsive sites:
- Naval Medical Center San Diego: < 24 hours
- University of Arizona-AHSC Bldg: < 24 hours
- VA Portland Health Care System: < 24 hours
Average response time
- < 2 Days